Lactobacillus paracasei endocarditis in a consumer of probiotics

Medecine et Maladies Infectieuses

Volumn 43, Issue 4, 2013, Pages 171-173

  Franko, B ^a   Vaillant, M ^a   Recule, C ^a   Vautrin, E ^a   Brion, J P ^a   Pavese, P ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; GENTAMICIN; PROBIOTIC AGENT;

AGED; BACTEREMIA; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CASE REPORT; CHILL; COLONOSCOPY; DRUG WITHDRAWAL; HIP PAIN; HUMAN; LACTOBACILLUS PARACASEI; LETTER; MALE; MEDICAL HISTORY; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; PROSTHESIS INFECTION; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTIMANIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BACTEREMIA; BACTERIAL TRANSLOCATION; BIPOLAR DISORDER; CHILLS; COLONOSCOPY; DELAYED DIAGNOSIS; DISEASE SUSCEPTIBILITY; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; GENTAMICINS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LACTOBACILLUS; LITHIUM CARBONATE; MALE; MITRAL VALVE INSUFFICIENCY; PROBIOTICS; PROSTATIC NEOPLASMS; PROSTHESIS-RELATED INFECTIONS; TIME FACTORS; YOGURT;

EID: 84878012154     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2013.01.007     Document Type: Letter

References (7)

1. Alvarez-Olmos M.I., Oberhelman R.A. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 2001, 32(11):1567-1576. [Epub 2001 May 4].
2. Cannon J.P., Lee T.A., Bolanos J.T., Danziger L.H. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 2005, 24(1):31-40.
3. Habib G., Hoen B., Tornos P., Thuny F., Prendergast B., Vilacosta I., et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 2009, 30(19):2369-2413. [Epub 2009 Aug 27].
4. Hoen B., Alla F., Selton-Suty C., Béguinot I., Bouvet A., Briançon S., et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002, 288(1):75-81.
5. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008, 371(9613):651-659. [Epub 2008 Feb 14].
6. McNaught C.E., Woodcock N.P., MacFie J., Mitchell C.J. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 2002, 51(6):827-831.
7. Salminen M.K., Tynkkynen S., Rautelin H., Saxelin M., Vaara M., Ruuta P., et al. Lactobacillus bacteremia during a rapid increase in probiotic. Use of Lactobacillus rhamonsus GG in Finland. Clin Infect Dis 2002, 35:1155-1160.